Covid-19 Vaccine: Drug maker Johnson & Johnson (J&J) has filed an application with the Indian drug regulator to study its Covid vaccine on children aged 12 to 17 years. The US company said it is committed to facilitating global access to its Covid vaccine and recognizing the unmet needs of children.
A Johnson & Johnson spokesperson in India said, “We have filed an application with the Central Drugs Standard Control Organization (CDSEO) on August 17, 2021 to study the Covid vaccine on children aged 12 to 17 years.”
A J&J spokesperson said that in order to achieve herd immunity, it is very important that the clinical trial of the Covid-19 vaccine continues. He said, “We are deeply committed to the important work needed to make our Covid vaccine equally easy for all age groups.”
It is noteworthy that earlier this month the central government approved the emergency use of Johnson & Johnson’s one-dose Covid vaccine in India. Serum Institute’s Covishield, Bharat Biotech’s Covaxin, Russia’s Sputnik V, Moderna and J&J have so far been approved for emergency use in India.